Chronic Lymphocytic Leukemia (CLL)
Patient Cafe® CLL
Four Chronic Lymphocytic Leukemia (CLL) patients got together to share their story and advice on dealing with a mid-life diagnosis, and how that can affect your personal and professional life.
CLL patient and host, Carol Preston, leads a panel of 5 other CLL patients from around the country to discuss treatment options and living well with their disease.
Ask the CLL Expert
Town Meeting Videos
Interview with Tina Sapienza, LMSW, OSW-C, Oncology Social Worker Columbia University Medical Center and Nicole Lamanna, MD, Associate Clinical Professor of Medicine Columbia University Medical Center
CLL patient advocate, Lee Swanson, interviews Dr. Adrian Wiestner, Senior Investigator, Laboratory of Lymphoid Malignancies National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health (NIH), about the exciting news in treatment of CLL.
CLL patient advocate, Lee Swanson, interviews Dr. Kerry Rogers, Assistant Professor, Department of Hematology The Ohio State University Medical Cener, about exciting CLL news and research from the ASH 2018 Conference.
Carol Preston interviews Dr. Andrew Zelenetz from Memorial Sloan Kettering in New York City about the recently presented results of the randomized, double-blind, placebo-controlled study of idelalisib in combination with Bendamustine and Rituximab for previously treated chronic lymphocytic leukemia. This trial asked the question, Could we take a standard of care treatment, that is, Bendamustine and Rituximab, a well-recognized standard of care, and improve upon it by the addition of idelalisib. This trial showed overwhelmingly positive results.